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Abstract The OmpR protein is an activator specific for the E, coli ompC and ompF genes. This protein functions in a phosphorylation-dependent 
manner through a presumed interaction with RNA polymerase. In this study we isolated OmpR mutants which were suggested tobe defective for 
transcriptional activation, but not for DNA binding. Two such mutants, that we isolated, have a single amino acid alteration at positions 131 [P131S], 
and 179 [P179L], respectively, of OmpR, comprising 239 amino acids. These altered amino acids in OmpR may be implicated, irectly or indirectly, 
in the presumed RNA polymerase/OmpR interaction that is important for transcriptional activation. 
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1. Introduction 2. Materials and methods 
In Escherichia coli, expression of the genes for major outer 
membrane proteins, OmpC and OmpF, is regulated at the tran- 
sciptional level in response to the medium osmolarity (for a 
review, see [1]). Whereas OmpR is the activator protein which 
binds to both the cognate ompC and ompF promoters, EnvZ 
is presumably a membrane-located osmotic sensor which exhib- 
its OmpR-specific kinase and apparent phosphatase activities. 
The EnvZ-mediated phosphorylation a d dephosphorylation 
of OmpR are crucial events in the osmoregulation. 
The molecular mechanism by which transcription is triggered 
through the coordinate functions of RNA polymerase and pos- 
itive regulators has been the general subject of longstanding 
debate in both prokaryotes and eukaryotes. In this context, 
OmpR is one of the best characterized bacterial positive regula- 
tors that somehow enhance the transcriptional ability of RNA 
polymerase. The N-terminal half of OmpR, comprising about 
120 amino acids, contains the site involved in phosphorylation, 
whereas the C-terminal half, containing about 120 amino acids, 
exhibits latent DNA-binding ability specific for cognate DNAs 
[2]. The DNA-binding ability of the C-terminal domain is mod- 
ulated through phosphorylation f the N-terminal domain, i.e. 
the phosphorylation f OmpR results in remarkable enhance- 
ment of its DNA-binding ability [3]. Several lines of evidence 
suggested that OmpR functions through a direct interaction 
with RNA polymerase [4-7]. A crucial question then arose, 
namely, whether or not there is any contact site (or activation 
site) with RNA polymerase in the primary sequence of the 
OmpR molecule. To address this mechanistic question, in this 
study we attempted to isolate an OmpR mutant which main- 
tains its phosphorylation-dependent DNA-binding ability, but 
lacks the ability to help RNA polymerase to activate the cog- 
nate promoters. Here we isolated such OmpR mutants and 
characterized them with emphasis on the mechanism underly- 
ing gene activation by OmpR. 
*Corresponding author. Fax: (81) (52) 789 4091. 
Abbreviations: PCR, polymerase chain reaction; bp, base pair(s); PC- 
mutant, positive control mutant. 
2.1. Bacterial strains and plasmids 
E. coli K-12 strain SG480A76, which lacks both the ompR and envZ 
genes, was mainly used in this study, unless otherwise noted [8]. Plasmid 
pCP-CSI was constructed previously [9]. Plasmid pBRC006 was con- 
structed from pSAC112B [10], in which the ampicillin resistance gene 
was replaced by the chloramphenicol resistance gene. 
2.2. Mutagenesis of the ompR gene with polymerase chain reaction 
(PCR) 
The SalI-EcoRI fragment from plasmid pBRC006 was subeloned 
into the corresponding sites in pUC19. The resultant plasmid was cut 
with Scal and subjected toPCR in the presence of0.3 mM MnCI2 with 
commercially available oligonucleotide primers (RV and M4, Takara 
Shuzo Co.). Other PCR-conditions were essentially the same as those 
described previously [11]. PCR products were treated with SalI-BgllI, 
and then cloned into the corresponding region of pBRC006 to yield a 
set of ompR mutants. 
2.3. DNA-binding assay 
Total cell lysate, used for DNA binding assay, was prepared as 
follows. E. coil DB225 [12], carrying each plasmid examined, were 
grown to the mid-logarithmic phase. The ceils were suspended in buffer 
containing 50 mM Tris-HCI (pH 8.0), 0.5 mM EDTA, 2 mM D1q', 5% 
glycerol, 50 mM KC1 and 0.05% Nonidet P40, and then disrupted by 
sonication. Using these lysates directly, DNA-binding assay was per- 
formed as follows. To phosphorylate OmpR in the cell lysate, 2 gl of 
EnvZl 1" (1/tg) [13], !.5/zl of 4 mM ATP and 1.5 gl of 50 mM MgCI2 
were added to 10gl of cell ysate, and then incubated for 20 rain at 37°C 
(lanes denoted by + in Fig. 2). As a control experiment, EnvZ11' and 
ATP were not added (lanes denoted by - in Fig. 2). To this sample, 
3.7 gl of 32P-labelled DNA probe was added. This DNA solution con- 
tained 0.56 ng of DNA, 240 ng of poly(dI~lC).poly(dI~lC) and 115 
mM EDTA. After incubation for 20 min at 24°C, the mixtures were 
immediately subjected to non-denaturing polyacrylamide g l electro- 
phoresis (6% acrylamide), followed by autoradiography, as described 
previously [21. 
3. Results 
We used a composite ompC promoter, as an appropriate 
reporter, which was fused to the lacZ gene on a plasmid (pCP- 
CSI), as shown in Fig. 1. In this promoter, a 20-bp sequence 
that functions as a high affinity OmpR-binding site was placed 
in front of the -35 and -10 sequences ofompC with an appro- 
priate spacer between them. This plasmid was introduced into 
strain SG480A76 (AompR, AenvZ, AlacZ). In the cells, this pro- 
moter-lacZ fusion gene was fully active, provided that the cells 
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Fig. 1. Schematic representation f experimental design. The structure 
of the plasmids, pCP-CS1 and pBRC006, were illustrated. The one 
(pCP-CS1) carries a simplified ompC promoter fused to the lacZ gene, 
whereas the other (pBRC006) carries both the ompR and envZ genes. 
The region subjected to PCR-mutagenesis was indicated for pBRC006. 
For other details, see the text. 
were concomitantly transformed with a plasmid (pBRC006) 
carrying both the ompR and envZ genes (Fig. 1). In other 
words, its transcription was effÉciently triggered in a phospho- 
OmpR-dependent manner, as judged from fl-galactosidase ac- 
tivity expressed (for example, see Fig. 4). The reason we used 
this particular promoter is as follows. Both the natural ompC 
and ompF promoters contain multiple OmpR-binding sites [14]. 
A complex interplay of these OmpR-binding sites appears to 
be implied not only in the activation, but also in the osmoreg- 
ulation of ompC and ompF. However, the simplified promoter 
should allow us to focus particularly on the process of the 
OmpR-dependent transcriptional activation, circumventing 
any other complexity (e.g. a presumed cooperative OmpR- 
OmpR interaction) with regard to the osmoregulation. It is 
worth mentioning that the level offl-galactosidase activity, ex- 
pressed in SG480A76 carrying both pCP-CS1 and pBRC006, 
was slightly higher (less than 2-fold) in Luria-broth containing 
0.4 M NaCI than in Luria-broth without NaCI. 
Based on the experimental rationale described above, we 
attempted to isolate an OmpR mutant hat fails to activate the 
promoter-lacZ fusion gene, but binds to the cognate OmpR- 
binding site. It was previously suggested that the C-terminal 
half of OmpR appears to possess the activation domain 
(Tsuzuki, Aiba and Mizuno, unpublished results). Thus, here 
plasmid pBRC006 was subjected to in vitro PCR-mutagenesis 
with appropriate primers, which together correspond to the 
region encoding the C-terminal half of OmpR. The SalI-BglII 
region encompassing the mutagenized region was isolated and 
ligated into the original plasmid (see Fig. 1). SG480A76 carrying 
the reporter plasmid was transformed with the resultant mix- 
ture of plasmids and then spread on lactose-MacConkey plates. 
The osmolarity of lactose-MacConkey plate was estimated to 
be intermediate, because both the ompC and ompF genes are 
efficiently expressed on this plate. Among about 104 transfor- 
mants, a number of white colonies appeared. They were sus- 
pected to contain a mutant plasmid producing an altered 
OmpR. Among them, those producing no or a reduced amount 
of OmpR in cells were discarded, through selecting by means 
of immuno-blotting analysis with an anti-OmpR antiserum. 
The remainder were subjected to the next critical selection 
procedure. 
To examine the ability of a given OmpR mutant o bind to 
the cognate DNA in an EnvZ (or phosphorylation)-dependent 
manner, we conducted an in vitro gel-shift assay. A crude cell 
lysate containing a given OmpR mutant was isolated on a small 
scale and then directly incubated with a 71-bp Y-end radiola- 
belled DNA fragment encompassing the OmpR-binding se- 
quence. In order to assess the phospho-OmpR dependency, the 
binding assay was carried out in either the absence or presence 
of purified form of EnvZ1 l* and ATE The samples were sub- 
jected to nondenaturing polyacrylamide gel electrophoresis, 
followed by autoradiography (Fig. 2). The results for a set of 
appropriate reference xperiments showed that one can easily 
assess whether or not a given OmpR mutant retains the ability 
to bind to the cognate DNA in phosphorylation-dependent 
manner (Fig. 2A). Under these conditions, for example, the 
wild-type OmpR exhibited a substantial DNA-binding ability 
in an phosphorylation-dependent manner (lanes 3 and 4), 
whereas the OmpR mutant, which lacks the crucial phos- 
phorylated site [Asp-55 to Gln], failed to do so (lanes 5 and 6). 
A number of putative OmpR mutants was then subjected to this 
analysis. Most of them were found to have lost their DNA- 
binding ability, suggesting that these OmpR mutants are defec- 
tive in either their intrinsic DNA-binding ability or in the proc- 
ess of their phosphorylation-dependent DNA-binding. They 
were also discarded, because in this study we did not intend to 
isolate these types. Out of 30 OmpR mutants examined, only 
two appeared to retain their phosphorylation-dependent DNA- 
binding ability. The results of gel-shift assaying of these two 
(tentatively named OmpR-4A and -10A) and a negative in- 
stance (named OmpR-10C) are shown in Fig. 2B. These results 
were confirmed further by mean of a quantitative DNA-bind- 
ing assay using various amounts of OmpR in cell lysates (Fig. 
3). Both OmpR-4A and -10A exhibited a significant ability to 
bind to the cognate DNA, as compared in the case of OmpR- 
10C. The ability of OmpR mutants to activate the promoter- 
lacZ fusion gene was finally confirmed in SG480A76 cells carry- 
ing pCP-CS1 by monitoring fl-galactosidase activity (Fig. 4). 
The cells producing each of OmpR-4A and -10A did indeed fail 
to express the promoter-lacZ fusion gene. From these results, 
we assumed that OmpR-4A and -10A may represent ones 
whose function is defective in a process of transcriptional cti- 
vation, but not in the process of DNA-binding. 
To examine the amino acid substitutions in these OmpR 
mutants, the nucleotide sequence was determined for the entire 
mutagenized region of each mutant plasmid (Fig. 5). In par- 
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Fig. 2. Phosphorylation dependent DNA binding assay. DNA-binding 
assay was carried out with a 32P-labeled DNA fragment encompassing 
the synthetic OmpR binding site, which was derived from pCP-CS1. 
Total cell lysates, containing approximately same amount of OmpR 
(15 rig) was subjected to DNA-binding assay, as described in section 
3. Note that OmpR-D55Q was characterized previously, which lacks 
the presumed phospho-accepting aspartate site [Asp-55]. 
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ticular, OmpR-4A and -10A were inferred to have a single 
amino acid substitution at positions 131, [Pro-131 to Ser] 
and179, [Pro-179 to Leu], respectively. These amino acid sub- 
stitutions are most likely responsible for the altered in vivo 
and in vitro properties observed for OmpR-4A and -10A, re- 
spectively. 
Here, the following questions remained to be answered. 
First, what would happen when these OmpR mutants were 
assessed as to the natural ompC and ompF promoters. Second, 
what would happen when these were assessed in the presence 
of the wild-type OmpR. To address these issues, a plasmid 
specifying either [P131S] or [P179L] was introduced into some 
strains, namely, DB225 (AompR, AenvZ) carrying an ompC- 
lacZ fusion gene; DB513 (AompR, AenvZ) carrying an ornpF- 
lacZ fusion gene; and MC4100 carrying pCP-CS1 (wild-type 
with respect o both the ompR and envZ genes). It should be 
noted that the ompC-lacZ and ompF-lacZ fusion were previ- 
ously constructed by means of Muc(Ts)-lac insertion on the 
chromosome, and were characterized as a transcriptional fu- 
sion. fl-Galactosidase activity expressed by these cells, trans- 
formed by the set of plasmids each specifying [P131S] or 
[P179L], were examined (Fig. 6). It was found that 
OmpR[P 179L] failed to activate both the ompC and ompF pro- 
moters, whereas OmpR[P 131 S] failed to activate the ompC pro- 
moter as expected, but could fully activate the ompF promoter. 
Essentially the same results were obtained irrespective of the 
medium osmolarity tested (data not shown, and see discussion). 
It was also found that these OmpR mutants, expressed from the 
high copy-number plasmid, exhibited a negative dominant 
character with respect to the wild-type OmpR, thereby 
MC4100 carrying pCP-CS1 exhibited a very low level of 
fl-galactosidase activity after the OmpR mutants had been in- 
troduced. 
4. Discussion 
It has been reported that certain amino acid substitutions in
the ~ subunit of RNA polymerase severely affect OmpR- 
dependent activation of in vivo ompC and/or ompF transcrip- 
tion [5-7], A reconstituted RNA polymerase containing C-ter- 
minally truncated ~subunits does not respond to in vitro tran- 
scription activation by certain activator proteins including 
OmpR [4]. These two independent lines of evidence strongly 
suggested that OmpR interacts with RNA polymerase (e.g. 
C 1 2 3 4 5 6 7 8 910 11121314151617181920 
Complex 
Free DNA ~'~ 
OmpR-4A OmpR-10A OmpR-10C OmpR-Wild 
Fig. 3. Quantitative DNA-binding assay. Total cell lysates, containing 
various amounts of OmpR were incubated with EnvZ 11 * and ATP, and 
then subjected to DNA-binding assay, as described in section 3. 
Amounts of OmpR in the lysates used were estimated to be 1.5 ng (lanes 
1, 6, 11, 16), 4.5 ng (lanes 2, 7, 12, 17), 15 ng (lanes 3, 8, 13, 18), 45 ng 
(lanes 4, 9, 14, 19) and 150 ng (lanes 5, 10, 15, 20). These estimations 
were based on the results of the quantitative immunoblotting analysis 
with an OmpR anti-serum. 
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Fig. 4. fl-Galactosidase activity expressed by the composite ornpC-lacZ 
fusion gene. Each mutant plasmid, including the original one 
(pBRC006), was transformed into SG480A76, which had carried plas- 
mid pCP-CS1. These cells were grown in Luria-broth to the mid-loga- 
rithmic phase, fl-Galactosidase activity expressed in these cells was 
examined as described by Miller [25] with modifications [9]. The values 
are an average of triplicated examinations. 
ct-subunit) during the processes of transcription initiation. 
OmpR may have certain contact sites (or activation domain) 
with RNA polymerase. An approach to verify such an activa- 
tion site of OmpR would be the isolation of mutants that bind 
to the cognate promoter normally, but fails to enhance one or 
more steps of transcriptional initiation (i.e., a positive control 
(PC) mutant). Several instances of such PC-mutants have been 
reported for the E. coli cyclic AMP receptor protein (CRP) 
[15-17]. In fact, such an approach allowed the identification of 
certain amino acids that may be involved in the interaction 
between CRP and RNA polymerase. Our OmpR mutants, iso- 
lated in this study, may be categorized as such PC-mutants. 
OmpR[P179L] seems more likely to be a PC-mutant han 
OmpR[P131S], because the former cannot activate transcrip- 
tion from not only the composite ompC promoter but also both 
the natural ompC and ompF promoters. However, the results 
of in vitro assaying showed that the DNA-binding ability of 
OmpR[P179L] is slightly less efficient, as compared with in the 
case of the wild-type. In this context, it is known that a crucial 
DNA-contact site is located in the C-terminal half of OmpR, 
within which the mutation of [P179L] is occurred (see Fig. 5). 
Therefore, it is tempting to assume that both the presumed 
transcriptional ctivation site and the DNA-contact domain 
may be in close proximity, from both structural and functional 
points of view. OmpR[P131 S] is also of interest in the sense that 
it retains normal ability to bind to the cognate DNA tested, but 
lacks the ability to activate transcription from both the compos- 
ite and natural ompC promoters, nevertheless it can activate the 
natural ompF transcription ormally. This can be interpreted 
formally as meaning that OmpR[P 131 S] is a PC-mutant specific 
for the ompC promoter. However, it is actually possible to 
envision several other complicated explanations, as discussed 
further below. If the former is the case, it is then interesting to 
assume that the activation site(s) in OmpR (or activation mech- 
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anisms for OmpR) are redundant, depending upon the type of 
promoter. An activation site(s) in OmpR for ompC may be 
somewhat different from the one for ornpF. We also learned 
from the previous papers from Silhavy's laboratory, in which 
a number of OmpR mutants have been systematically isolated 
and genetically characterized, that one such mutant is identical 
to OmpR[P131S] [18,19]. Since their mutant, OmpR[PI31S], 
can trigger the ompF expression constitutively regardless of the 
medium osmolarity, they categorized this mutant as a 'ompF 
repression mutant' (it should be noted that ompF transcription 
was proposed to be repressed under certain conditions through 
the function of OmpR that binds to 'repression sites') [18,19]. 
They also reported that OmpR[P131S] can trigger the ompC 
transcription particularly in the high osmolarity medium (or in 
a certain envZ mutant background), albeit with a lower effi- 
ciency as compared with in the case of the wild-type OmpR [18]. 
In fact, we also found that when DB225 producing our 
OmpR[P131S] was grown in Luria-broth containing 0.4 M 
NaCI, the cells exhibited significantly higher fl-galactosidase 
activity (data not shown, and see Fig. 6). However, the level of 
fl-galactosidase activity observed for OmpR[P131 S] in the high 
osmolarity medium was still markedly lower than that observed 
for the wild-type OmpR (data not shown). It should be also 
emphasized that we further demonstrated quantitatively in
vitro that OmpR[P131 S] retains its DNA-binding ability as well 
as the wild-type, but is unable to trigger the ompC transcription 
from pCP-CS 1. These results are compatible with the view that 
OmpR[P131S] is defective, if not completely, in the ability to 
trigger the ompC transcription. In this context, the repression 
mutant model (proposed for ompF) and the positive control 
mutant model (proposed for ompC) are not mutually exclusive. 
In any case, it is of interest o isolate extragenic suppressor 
mutations for our OmpR mutants in order to see if they are 
found in any one of the components of RNA polymerase. 
It should be briefly mentioned that both OmpR[Pl 31 S] and 
OmpR[P179L] exhibit a negative dominant character with re- 
spect to the wild-type OmpR. This observation is compatible 
with the view that they are PC-mutants. However, this issue 
must carefully be examined, because we used a high copy- 
number plasmid carrying these ompR mutant alleles. Therefore, 
a number of other explanations might be possible. 
In conclusion, we isolated OmpR mutants which are tenta- 
tively categorized in a type of PC-mutants. A number of OmpR 
mutants, exhibiting a wide variety of phenotypes as to ompC 
and ompF expression, has been reported by several groups 
including ours [18-23]. Among them, however, no obvious PC- 
mutant has been characterized in detail so far, although Silhavy 
and his colleagues have noted some candidates for PC-mutants 
[18]. It should be noted that OmpR[P179L] is a novel one in this 
< ) 
°mPal I [ 
Ompa-4A 
OmpR*lOA 
Ompn-lOC 
Pro-131 to 
P1'o-179 tO Leu 
Met-211 to Viii 
VM-212 to Ale 
Fig. 5. Amino acid substitutions of the OmpR mutants. Amino acid 
substitutions, identified for the set of OmpR mutants, are shown in the 
schematic structure of OmpR. Numbers indicate positions of altered 
amino acids, the N-terminal methionine being taken as 1. 
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Fig. 6. fl-Galactosidase activity expressed by the ompC-lacZ and ompF- 
lacZ fusion genes. Each mutant plasmid was transferred into either 
DB225 carrying an ompC-lacZ fusion gene (panel A), DB513 carrying 
an ompF-lacZ fusion gene (panel B), or MC4100 carrying pCP-CS1 
(panel C). Cells were grown either in Luria-broth (panels A and C) or 
NaCl-deprived Luria-broth (panel B) (a reference for these strain is 
reference [12]). fl-Galactosidase activity expressed in these cells was 
examined as described by Miller [25] with modifications [9]. The values 
are an average of triplicated examinations. 
sense. Further characterization f these intriguing OmpR mu- 
tants should shed light on the general mechanism underlying 
transcriptional ctivation in prokaryotes, ince a number of 
E. coli activator proteins belongs to the so-called OmpR-sub- 
family, including 8 known members o far, whose amino acid 
sequences are extensively similar to each other not only in the 
N-terminal phosphorylation domain but also in the C-terminal 
DNA-binding domain [24]. 
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